Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
20,898,775
-
Share change
-
+248,180
-
Total reported value
-
$585,169,000
-
Price per share
-
$28.00
-
Number of holders
-
34
-
Value change
-
+$9,050,404
-
Number of buys
-
16
-
Number of sells
-
15
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2017
As of 31 Mar 2017,
Ascendis Pharma A/S - ADR (ASND) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,898,775 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, FMR LLC, ORBIMED ADVISORS LLC, Vivo Capital, LLC, BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, DEERFIELD MANAGEMENT CO, VHCP Management II, LLC, venBio Select Advisor LLC, and JANUS CAPITAL MANAGEMENT LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.